,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['tnbc', 'breast', 'destiny-breast04']
#asco22. destiny-breast04. tdxd shows benefit in herlow breast cancer patients - impressive results - practice changing!!! # tnbc amazing results 
Breast oncologist, Director of Cancer Center @MethodistHosp @HMethodistMD#bccww#bcsm#cancer